Recombinant Two-component COVID-19 Vaccine (CHO Cell)

· Jiangsu Rec-Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Two-component COVID-19 Vaccine (CHO Cell), covering 2024-02-29 to 2024-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety, and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) [Phase 2]

See pricing